La Roche sur Foron, France

Samuel Gavard Molliard


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Samuel Gavard Molliard: Innovator in Injectable Formulations

Introduction

Samuel Gavard Molliard is a notable inventor based in La Roche sur Foron, France. He has made significant contributions to the field of injectable formulations, particularly in the treatment of osteoarthritis. With a total of 2 patents to his name, Molliard's work focuses on developing innovative solutions for joint degeneration.

Latest Patents

Molliard's latest patents include an injectable formulation of natural polysaccharide and polyol for the treatment of osteoarthritis. This sterile injectable aqueous formulation is designed as a gel made up of hyaluronic acid or a salt thereof, combined with one or more polyols. The gel can be applied to the intra-articular area, effectively addressing joint degeneration and osteoarthritis. The formulation exhibits rheological properties similar to synovial fluid and demonstrates enhanced resistance to degradation due to the synergistic action between hyaluronic acid and polyols. Another significant patent involves the use of a natural polysaccharide gel for preparing an injectable formulation aimed at treating articular degeneration. This formulation also consists of hyaluronic acid, with or without additional natural polysaccharides, and one or more polyols, ensuring effective intra-articular application.

Career Highlights

Samuel Gavard Molliard is currently associated with Aptissen SA, where he continues to innovate in the field of medical formulations. His expertise and dedication to research have positioned him as a key player in developing advanced treatments for joint-related ailments.

Collaborations

Molliard collaborates with Olivier Benoit, contributing to the advancement of their shared goals in the field of injectable formulations.

Conclusion

Samuel Gavard Molliard's work in developing injectable formulations for osteoarthritis showcases his commitment to improving patient care through innovation. His contributions are paving the way for more effective treatments in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…